{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T23:15:14Z","timestamp":1790810114021,"version":"4.1.0"},"reference-count":91,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["ajog.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.ajog.2026.02.041","type":"journal-article","created":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T07:53:20Z","timestamp":1772524400000},"page":"409-420","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["The accuracy of the soluble fms-like tyrosine kinase 1\/placental growth factor ratio assay in predicting time to delivery in patients with suspected preeclampsia"],"prefix":"10.1016","volume":"235","author":[{"given":"Siobhan","family":"Wilson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine","family":"Carson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul M.","family":"Yip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle A.","family":"Hladunewich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Kingdom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2704-1385","authenticated-orcid":false,"given":"Nir","family":"Melamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajog.2026.02.041_bib1","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0140-6736(20)32335-7","article-title":"Pre-eclampsia","volume":"398","author":"Chappell","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.ajog.2026.02.041_bib2","series-title":"Delivery Hospitalizations Involving Preeclampsia and Eclampsia, 2005-2014","author":"Fingar","year":"2006"},{"key":"10.1016\/j.ajog.2026.02.041_bib3","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1161\/CIRCRESAHA.118.313276","article-title":"Preeclampsia: pathophysiology, challenges, and perspectives","volume":"124","author":"Rana","year":"2019","journal-title":"Circ Res"},{"key":"10.1016\/j.ajog.2026.02.041_bib4","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1161\/HYPERTENSIONAHA.117.10803","article-title":"Hypertensive disorders of pregnancy: ISSHP classification, diagnosis, and management recommendations for International practice","volume":"72","author":"Brown","year":"2018","journal-title":"Hypertension"},{"key":"10.1016\/j.ajog.2026.02.041_bib5","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1080\/10641955.2016.1190846","article-title":"Preeclampsia and preterm delivery: a population-based case-control study","volume":"35","author":"Davies","year":"2016","journal-title":"Hypertens Pregnancy"},{"key":"10.1016\/j.ajog.2026.02.041_bib6","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1471-0528.1990.tb01711.x","article-title":"The effects of corticosteroid administration before preterm delivery: an overview of the evidence from controlled trials","volume":"97","author":"Crowley","year":"1990","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.ajog.2026.02.041_bib7","first-page":"1","article-title":"Effect of corticosteroids for fetal maturation on perinatal outcomes","volume":"12","year":"1994","journal-title":"NIH Consens Statement"},{"key":"10.1016\/j.ajog.2026.02.041_bib8","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/0002-9378(95)90222-8","article-title":"Antenatal corticosteroid therapy: a meta-analysis of the randomized trials, 1972 to 1994","volume":"173","author":"Crowley","year":"1995","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2026.02.041_bib9","article-title":"Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth","volume":"3","author":"Roberts","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ajog.2026.02.041_bib10","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1001\/jama.1995.03520290065031","article-title":"NIH consensus development panel on the effect of corticosteroids for fetal maturation on perinatal outcomes","volume":"273","year":"1995","journal-title":"JAMA"},{"key":"10.1016\/j.ajog.2026.02.041_bib11","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1111\/1471-0528.16511","article-title":"Benefit of antenatal corticosteroids by year of birth among preterm infants in Canada during 2003-2017: a population-based cohort study","volume":"128","author":"Melamed","year":"2021","journal-title":"BJOG"},{"key":"10.1016\/j.ajog.2026.02.041_bib12","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/j.jogc.2018.04.018","article-title":"No. 364-Antenatal corticosteroid therapy for improving neonatal outcomes","volume":"40","author":"Skoll","year":"2018","journal-title":"J Obstet Gynaecol Can"},{"key":"10.1016\/j.ajog.2026.02.041_bib13","first-page":"CD004454","article-title":"Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth","volume":"12","author":"McGoldrick","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ajog.2026.02.041_bib14","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1542\/peds.50.4.515","article-title":"A controlled trial of antepartum glucocorticoid treatment for prevention of the respiratory distress syndrome in premature infants","volume":"50","author":"Liggins","year":"1972","journal-title":"Pediatrics"},{"key":"10.1016\/j.ajog.2026.02.041_bib15","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1046\/j.0004-8666.2003.00052.x","article-title":"Effects of a single course of corticosteroids given more than 7 days before birth: a systematic review","volume":"43","author":"McLaughlin","year":"2003","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"10.1016\/j.ajog.2026.02.041_bib16","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD004454.pub2","article-title":"Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth","volume":"3","author":"Roberts","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ajog.2026.02.041_bib17","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/ijgo.13836","article-title":"FIGO good practice recommendations on the use of prenatal corticosteroids to improve outcomes and minimize harm in babies born preterm","volume":"155","author":"Norman","year":"2021","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.ajog.2026.02.041_bib18","doi-asserted-by":"crossref","first-page":"e102","DOI":"10.1097\/AOG.0000000000002237","article-title":"Committee opinion no. 713: antenatal corticosteroid therapy for fetal maturation","volume":"130","year":"2017","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2026.02.041_bib19","doi-asserted-by":"crossref","first-page":"457.e1-6","DOI":"10.1016\/j.ajog.2006.12.018","article-title":"The effect of a prolonged time interval between antenatal corticosteroid administration and delivery on outcomes in preterm neonates: a cohort study","volume":"196","author":"Ring","year":"2007","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2026.02.041_bib20","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1080\/14767050802559095","article-title":"Impact of timing of antenatal corticosteroid exposure on neonatal outcomes","volume":"22","author":"Waters","year":"2009","journal-title":"J Matern Fetal Neonatal Med"},{"key":"10.1016\/j.ajog.2026.02.041_bib21","doi-asserted-by":"crossref","first-page":"256.e1-7","DOI":"10.1016\/j.ajog.2013.06.020","article-title":"Optimal time interval between a single course of antenatal corticosteroids and delivery for reduction of respiratory distress syndrome in preterm twins","volume":"209","author":"Kuk","year":"2013","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2026.02.041_bib22","first-page":"491","article-title":"Is betamethasone effective longer than 7 days after treatment?","volume":"97","author":"Vermillion","year":"2001","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2026.02.041_bib23","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1016\/j.ajog.2004.06.055","article-title":"The effects of the time interval from antenatal corticosteroid exposure to delivery on neonatal outcome of very low birth weight infants","volume":"191","author":"Sehdev","year":"2004","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2026.02.041_bib24","doi-asserted-by":"crossref","first-page":"86","DOI":"10.5152\/jtgga.2011.21","article-title":"Comparison of interval duration between single course antenatal corticosteroid administration and delivery on neonatal outcomes","volume":"12","author":"Sekhavat","year":"2011","journal-title":"J Turk Ger Gynecol Assoc"},{"key":"10.1016\/j.ajog.2026.02.041_bib25","doi-asserted-by":"crossref","first-page":"49.e1-7","DOI":"10.1016\/j.ajog.2011.03.035","article-title":"Relationship between the time interval from antenatal corticosteroid administration until preterm birth and the occurrence of respiratory morbidity","volume":"205","author":"Wilms","year":"2011","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2026.02.041_bib26","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/j.ajog.2005.06.050","article-title":"The interval between a single course of antenatal steroids and delivery and its association with neonatal outcomes","volume":"193","author":"Peaceman","year":"2005","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2026.02.041_bib27","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1136\/bmj.39225.677708.80","article-title":"Decline in effectiveness of antenatal corticosteroids with time to birth: real or artefact?","volume":"335","author":"Gates","year":"2007","journal-title":"BMJ"},{"key":"10.1016\/j.ajog.2026.02.041_bib28","doi-asserted-by":"crossref","first-page":"B2","DOI":"10.1016\/j.ajog.2022.02.021","article-title":"Society for maternal-fetal medicine special statement: quality metrics for optimal timing of antenatal corticosteroid administration","volume":"226","author":"Hamm","year":"2022","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2026.02.041_bib29","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2025.11315","article-title":"Timing of antenatal corticosteroid administration and neonatal outcomes","volume":"8","author":"Melamed","year":"2025","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.ajog.2026.02.041_bib30","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1097\/AOG.0000000000000840","article-title":"Association between antenatal corticosteroid administration-to-birth interval and outcomes of preterm neonates","volume":"125","author":"Melamed","year":"2015","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2026.02.041_bib31","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1111\/1471-0528.13970","article-title":"Antenatal corticosteroids are currently used excessively and more stringent controls on their use should be established: AGAINST: current use of antenatal corticosteroids effectively reduces neonatal morbidity and mortality","volume":"123","author":"Levin","year":"2016","journal-title":"BJOG"},{"key":"10.1016\/j.ajog.2026.02.041_bib32","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.jogc.2018.06.001","article-title":"Use of antenatal corticosteroid therapy: a descriptive study of clinical practice trends","volume":"41","author":"Fillion","year":"2019","journal-title":"J Obstet Gynaecol Can"},{"key":"10.1016\/j.ajog.2026.02.041_bib33","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1001\/jamapediatrics.2017.0602","article-title":"Association of short antenatal corticosteroid administration-to-birth intervals with survival and morbidity among very preterm infants: results from the EPICE cohort","volume":"171","author":"Norman","year":"2017","journal-title":"JAMA Pediatr"},{"key":"10.1016\/j.ajog.2026.02.041_bib34","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1055\/s-0031-1280596","article-title":"Time to delivery after the first course of antenatal corticosteroids: a cohort study","volume":"28","author":"Vis","year":"2011","journal-title":"Am J Perinatol"},{"key":"10.1016\/j.ajog.2026.02.041_bib35","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1111\/1471-0528.14545","article-title":"Timing of antenatal corticosteroid administration and survival in extremely preterm infants: a national population-based cohort study","volume":"124","author":"Norberg","year":"2017","journal-title":"BJOG"},{"key":"10.1016\/j.ajog.2026.02.041_bib36","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1097\/AOG.0000000000000629","article-title":"Trends in optimal, suboptimal, and questionably appropriate receipt of antenatal corticosteroid prophylaxis","volume":"125","author":"Razaz","year":"2015","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2026.02.041_bib37","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/S1701-2163(16)30626-0","article-title":"Do we use too much antenatal betamethasone?","volume":"24","author":"Skoll","year":"2002","journal-title":"J Obstet Gynaecol Can"},{"key":"10.1016\/j.ajog.2026.02.041_bib38","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.3109\/14767058.2014.962508","article-title":"Practice patterns in the timing of antenatal corticosteroids for fetal lung maturity","volume":"28","author":"Adams","year":"2015","journal-title":"J Matern Fetal Neonatal Med"},{"key":"10.1016\/j.ajog.2026.02.041_bib39","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/S0140-6736(22)01535-5","article-title":"Neonatal outcomes for women at risk of preterm delivery given half dose versus full dose of antenatal betamethasone: a randomised, multicentre, double-blind, placebo-controlled, non-inferiority trial","volume":"400","author":"Schmitz","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.ajog.2026.02.041_bib40","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1172\/JCI17189","article-title":"Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia","volume":"111","author":"Maynard","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ajog.2026.02.041_bib41","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/nm1429","article-title":"Soluble endoglin contributes to the pathogenesis of preeclampsia","volume":"12","author":"Venkatesha","year":"2006","journal-title":"Nat Med"},{"key":"10.1016\/j.ajog.2026.02.041_bib42","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1097\/AOG.0000000000005532","article-title":"Angiogenic biomarkers in preeclampsia","volume":"143","author":"Burwick","year":"2024","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2026.02.041_bib43","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s11906-017-0706-5","article-title":"Anti-angiogenesis and preeclampsia in 2016","volume":"19","author":"Schrey-Petersen","year":"2017","journal-title":"Curr Hypertens Rep"},{"key":"10.1016\/j.ajog.2026.02.041_bib44","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1056\/NEJMoa1414838","article-title":"Predictive value of the sFlt-1:PlGF ratio in women with suspected preeclampsia","volume":"374","author":"Zeisler","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajog.2026.02.041_bib45","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1161\/HYPERTENSIONAHA.119.13763","article-title":"Combining biomarkers to predict pregnancy complications and redefine preeclampsia: the angiogenic-placental syndrome","volume":"75","author":"Stepan","year":"2020","journal-title":"Hypertension"},{"key":"10.1016\/j.ajog.2026.02.041_bib46","doi-asserted-by":"crossref","first-page":"S844","DOI":"10.1016\/j.ajog.2021.11.1356","article-title":"The etiology of preeclampsia","volume":"226","author":"Jung","year":"2022","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2026.02.041_bib47","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1016\/S0140-6736(18)33212-4","article-title":"Placental growth factor testing to assess women with suspected pre-eclampsia: a multicentre, pragmatic, stepped-wedge cluster-randomised controlled trial","volume":"393","author":"Duhig","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.ajog.2026.02.041_bib48","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1111\/1471-0528.12195","article-title":"Angiogenic factors combined with clinical risk factors to predict preterm pre-eclampsia in nulliparous women: a predictive test accuracy study","volume":"120","author":"Myers","year":"2013","journal-title":"BJOG"},{"key":"10.1016\/j.ajog.2026.02.041_bib49","doi-asserted-by":"crossref","DOI":"10.1056\/EVIDoa2200161","article-title":"Circulating angiogenic factor levels in hypertensive disorders of pregnancy","volume":"1","author":"Thadhani","year":"2022","journal-title":"NEJM Evid"},{"key":"10.1016\/j.ajog.2026.02.041_bib50","doi-asserted-by":"crossref","first-page":"573.e1-e11","DOI":"10.1016\/j.ajog.2022.10.044","article-title":"The additive role of angiogenic markers for women with confirmed preeclampsia","volume":"228","author":"Suresh","year":"2023","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2026.02.041_bib51","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1002\/uog.26032","article-title":"Clinical utility of sFlt-1 and PlGF in screening, prediction, diagnosis and monitoring of pre-eclampsia and fetal growth restriction","volume":"61","author":"Stepan","year":"2023","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ajog.2026.02.041_bib52","article-title":"Diagnosis and management of hypertension in pregnancy: summary of updated NICE guidance","volume":"366","author":"Webster","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.ajog.2026.02.041_bib53","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1161\/HYPERTENSIONAHA.119.12739","article-title":"Randomized interventional study on prediction of preeclampsia\/eclampsia in women with suspected preeclampsia: INSPIRE","volume":"74","author":"Cerdeira","year":"2019","journal-title":"Hypertension"},{"key":"10.1016\/j.ajog.2026.02.041_bib55","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.preghy.2021.09.008","article-title":"The 2021 International Society for the study of hypertension in pregnancy classification, diagnosis & management recommendations for international practice","volume":"27","author":"Magee","year":"2022","journal-title":"Pregnancy Hypertens"},{"key":"10.1016\/j.ajog.2026.02.041_bib56","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.jogc.2022.03.002","article-title":"Guideline no. 426: hypertensive disorders of pregnancy: diagnosis, prediction, prevention, and management","volume":"44","author":"Magee","year":"2022","journal-title":"J Obstet Gynaecol Can"},{"issue":"Suppl 1","key":"10.1016\/j.ajog.2026.02.041_bib58","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/ijgo.13763","volume":"154","author":"Poon","year":"2021","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.ajog.2026.02.041_bib59","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/AOG.0000000000001525","article-title":"Soluble fms-like tyrosine Kinase-1-to-Placental growth factor ratio and time to delivery in women with suspected preeclampsia","volume":"128","author":"Zeisler","year":"2016","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2026.02.041_bib60","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1002\/uog.19178","article-title":"Soluble fms-like tyrosine kinase-1 to placental growth factor ratio: ruling out pre-eclampsia for up to 4 weeks and value of retesting","volume":"53","author":"Zeisler","year":"2019","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ajog.2026.02.041_bib61","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1055\/a-2497-8104","article-title":"Risk for imminent delivery in preeclampsia based on the sFlt-1\/PlGF ratio: do we need new cut-offs?","volume":"85","author":"Enengl","year":"2025","journal-title":"Geburtshilfe Frauenheilkd"},{"key":"10.1016\/j.ajog.2026.02.041_bib62","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1161\/HYPERTENSIONAHA.120.15146","article-title":"Prediction of Preeclampsia-Related Adverse Outcomes with the sFlt-1 (Soluble fms-Like Tyrosine Kinase 1)\/PlGF (placental Growth Factor)-Ratio in the Clinical Routine: a Real-World Study","volume":"77","author":"Droge","year":"2021","journal-title":"Hypertension"},{"key":"10.1016\/j.ajog.2026.02.041_bib65","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1161\/HYPERTENSIONAHA.119.13997","article-title":"Angiogenic marker prognostic models in pregnant women with hypertension","volume":"75","author":"Perry","year":"2020","journal-title":"Hypertension"},{"key":"10.1016\/j.ajog.2026.02.041_bib66","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s00404-019-05365-9","article-title":"Role of sFlt-1\/PlGF ratio and feto-maternal doppler for the prediction of adverse perinatal outcome in late-onset pre-eclampsia","volume":"301","author":"Graupner","year":"2020","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.ajog.2026.02.041_bib67","first-page":"1","article-title":"Placental Growth Factor (PlGF)- based biomarker testing to help diagnose pre-eclampsia in people with suspected pre-eclampsia: a health technology assessment","volume":"23","author":"Ontario","year":"2023","journal-title":"Ont Health Technol Assess Ser"},{"key":"10.1016\/j.ajog.2026.02.041_bib70","first-page":"1122","article-title":"Hypertension in pregnancy. Report of the American College of obstetricians and gynecologists' task force on hypertension in pregnancy","volume":"122","year":"2013","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2026.02.041_bib71","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1148\/radiology.181.1.1887021","article-title":"In utero analysis of fetal growth: a sonographic weight standard","volume":"181","author":"Hadlock","year":"1991","journal-title":"Radiology"},{"key":"10.1016\/j.ajog.2026.02.041_bib72","doi-asserted-by":"crossref","DOI":"10.1542\/peds.108.2.e35","article-title":"A new and improved population-based Canadian reference for birth weight for gestational age","volume":"108","author":"Kramer","year":"2001","journal-title":"Pediatrics"},{"key":"10.1016\/j.ajog.2026.02.041_bib73","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1093\/jalm\/jfab135","article-title":"Analytical performance and quality indicators of fully automated immunoassays for sFlt-1 and PlGF","volume":"7","author":"Higgins","year":"2022","journal-title":"J Appl Lab Med"},{"key":"10.1016\/j.ajog.2026.02.041_bib74","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1093\/jalm\/jfad003","article-title":"Clinical validation of the sFlt-1:PlGF ratio as a biomarker for preeclampsia diagnosis in a high-risk obstetrics unit","volume":"8","author":"Miller","year":"2023","journal-title":"J Appl Lab Med"},{"key":"10.1016\/j.ajog.2026.02.041_bib75","doi-asserted-by":"crossref","first-page":"58.e1","DOI":"10.1016\/j.ajog.2011.07.037","article-title":"The sFlt-1\/PlGF ratio in different types of hypertensive pregnancy disorders and its prognostic potential in preeclamptic patients","volume":"206","author":"Verlohren","year":"2012","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2026.02.041_bib76","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajogmf.2019.100077","article-title":"Optimal timing of antenatal corticosteroid administration and preterm neonatal and early childhood outcomes","volume":"2","author":"Battarbee","year":"2020","journal-title":"Am J Obstet Gynecol MFM"},{"key":"10.1016\/j.ajog.2026.02.041_bib77","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.ajog.2006.03.087","article-title":"Single versus weekly courses of antenatal corticosteroids: evaluation of safety and efficacy","volume":"195","author":"Wapner","year":"2006","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2026.02.041_bib78","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1016\/S0140-6736(08)61929-7","article-title":"Multiple courses of antenatal corticosteroids for preterm birth (MACS): a randomised controlled trial","volume":"372","author":"Murphy","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.ajog.2026.02.041_bib79","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.biopsych.2013.03.009","article-title":"Fetal glucocorticoid exposure is associated with preadolescent brain development","volume":"74","author":"Davis","year":"2013","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.ajog.2026.02.041_bib80","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.psyneuen.2016.06.012","article-title":"Antenatal glucocorticoid treatment is associated with diurnal cortisol regulation in term-born children","volume":"72","author":"Edelmann","year":"2016","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.ajog.2026.02.041_bib81","doi-asserted-by":"crossref","first-page":"3538","DOI":"10.1210\/jc.2012-1970","article-title":"Impact of antenatal synthetic glucocorticoid exposure on endocrine stress reactivity in term-born children","volume":"97","author":"Alexander","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ajog.2026.02.041_bib82","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1186\/1471-2393-14-272","article-title":"Association between gestational age at birth, antenatal corticosteroids, and outcomes at 5 years: multiple courses of antenatal corticosteroids for preterm birth study at 5 years of age (MACS-5)","volume":"14","author":"Asztalos","year":"2014","journal-title":"BMC Pregnancy Childbirth"},{"key":"10.1016\/j.ajog.2026.02.041_bib83","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1136\/bmj.38547.416493.06","article-title":"Antenatal betamethasone and incidence of neonatal respiratory distress after elective caesarean section: pragmatic randomised trial","volume":"331","author":"Stutchfield","year":"2005","journal-title":"BMJ"},{"key":"10.1016\/j.ajog.2026.02.041_bib84","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jogc.2016.05.011","article-title":"We should proceed with caution when it comes to antenatal corticosteroids after 34 weeks","volume":"39","author":"Nowik","year":"2017","journal-title":"J Obstet Gynaecol Can"},{"key":"10.1016\/j.ajog.2026.02.041_bib85","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1001\/jamapediatrics.2014.9","article-title":"Antenatal glucocorticoids prior to cesarean delivery at term","volume":"168","author":"Aiken","year":"2014","journal-title":"JAMA Pediatr"},{"key":"10.1016\/j.ajog.2026.02.041_bib86","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1111\/1471-0528.13968","article-title":"Antenatal corticosteroids are currently used excessively and more stringent controls on their use should be established: for: the use of antenatal corticosteroids should be restricted if we are to avoid causing harm","volume":"123","author":"Asztalos","year":"2016","journal-title":"BJOG"},{"key":"10.1016\/j.ajog.2026.02.041_bib87","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ajog.2018.04.007","article-title":"Antenatal corticosteroids: an assessment of anticipated benefits and potential risks","volume":"219","author":"Jobe","year":"2018","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2026.02.041_bib88","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2019-031197","article-title":"Neurodevelopmental disorders among term infants exposed to antenatal corticosteroids during pregnancy: a population-based study","volume":"9","author":"Melamed","year":"2019","journal-title":"BMJ Open"},{"key":"10.1016\/j.ajog.2026.02.041_bib89","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1001\/jama.2020.3937","article-title":"Associations between maternal antenatal corticosteroid treatment and mental and behavioral disorders in children","volume":"323","author":"Raikkonen","year":"2020","journal-title":"Jama"},{"key":"10.1016\/j.ajog.2026.02.041_bib90","first-page":"592","article-title":"A growing dilemma: antenatal corticosteroids and long-term consequences","volume":"39","author":"Asztalos","year":"2020","journal-title":"Am J Perinatol"},{"key":"10.1016\/j.ajog.2026.02.041_bib91","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.910701","article-title":"Prediction of delivery within 7 days after diagnosis of early onset preeclampsia using machine-learning models","volume":"9","author":"Villalain","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.ajog.2026.02.041_bib92","article-title":"Predictive modeling of complications arising from early-onset preeclampsia in pregnant women","volume":"21","author":"Dominguez Del Olmo","year":"2025","journal-title":"Womens Health (Lond)"},{"key":"10.1016\/j.ajog.2026.02.041_bib93","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.preghy.2020.07.007","article-title":"sFlt-1\/PlGF ratio for the prediction of delivery within 48 hours and adverse outcomes in expectantly managed early-onset preeclampsia","volume":"22","author":"Simon","year":"2020","journal-title":"Pregnancy Hypertens"},{"key":"10.1016\/j.ajog.2026.02.041_bib94","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1002\/uog.13224","article-title":"Uterine artery doppler and sFlt-1\/PlGF ratio: prognostic value in early-onset pre-eclampsia","volume":"43","author":"Gomez-Arriaga","year":"2014","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ajog.2026.02.041_bib95","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.015548","article-title":"Maternal and perinatal outcomes associated with extremely high values for the sFlt-1 (soluble fms-Like tyrosine kinase 1)\/PlGF (Placental Growth Factor) ratio","volume":"9","author":"Villalain","year":"2020","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.ajog.2026.02.041_bib96","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1159\/000517391","article-title":"Development of a third trimester contingent prognostic prediction scheme for suspected early-onset pre-eclampsia","volume":"48","author":"Sabria","year":"2021","journal-title":"Fetal Diagn Ther"},{"key":"10.1016\/j.ajog.2026.02.041_bib97","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/6270187","article-title":"Maternal serum angiogenic factor sFlt-1 to PlGF ratio in preeclampsia: a useful marker for differential diagnosis and prognosis evaluation in Chinese women","volume":"2019","author":"Lou","year":"2019","journal-title":"Dis Markers"}],"container-title":["American Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937826001249?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937826001249?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T00:34:09Z","timestamp":1790123649000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002937826001249"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":91,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S0002937826001249"],"URL":"https:\/\/doi.org\/10.1016\/j.ajog.2026.02.041","relation":{},"ISSN":["0002-9378"],"issn-type":[{"value":"0002-9378","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The accuracy of the soluble fms-like tyrosine kinase 1\/placental growth factor ratio assay in predicting time to delivery in patients with suspected preeclampsia","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics and Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajog.2026.02.041","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}